Business
Pfizer says trials show COVID-19 antiviral pill cuts hospitalisation and death risk by nearly 90 per cent – ABC News
Pfizer will ask regulators for the pill to be made available for global use as soon as possible after clinical trials suggested…
Pfizer says its experimental antiviral pill for COVID-19 cut rates of hospitalisation and death by nearly 90 per cent in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus.
Key points:
- Pfizer says preliminary…
Continue Reading
-
Noosa News17 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
Noosa News19 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General22 hours agoOne person dead after house fire in Melbourne’s south-east
-
Noosa News15 hours agoFranz Ferdinand: Australian Tour 2025